Prot#AC-055G203: A Long-Term, Multicenter, Single-Arm, Open-Label Extension of the SERENADE Study, to Assess the Safety and Efficacy of Macitentan in Subjects with Heart Failure with Preserved Ejection Fraction and Pulmonary Vascular Disease